CROI 2018 – The Official UNMC ID Guide of Where We Will Be!

CROI 2018 is here and we want to be sure YOU know where to find us in Boston. Below is the list of faculty presentations and posters from our Division. Come visit us at CROI – We would LOVE to meet you! Find us on Twitter @UNMC_ID ; #UNMCID

Content courtesy of Kim Scarsi, Sue Swindells and the entire HIV group at UNMC ID

Oral presentations:

Monday March 5 2018, 11:15am (in Oral Abstract O-02 ART: New Data and new insights, Auditorium) 

Abstract 27: COMPARATIVE LYMPHOID TISSUE PHARMACOKINETICS (PK) OF INTEGRASE INHIBITORS (INSTI) 

Courtney V. Fletcher, Ann Thorkelson, Lee Winchester, Timothy Mykris, Jon Weinhold, Kayla Campbell, Jodi Anderson, Jacob Zulk, Puleng Moshele, Timothy Schacker

*****

Monday March 5 2018, 11:40 AM to 11:50 AM (in Oral Abstract O-03: ADVANCES IN TB AND CRYPTOCOCCAL MENINGITIS TREATMENT AND PREVENTION, Ballroom C)

Late-Breaker Abstract 37LB: ONE MONTH OF RIFAPENTINE/ISONIAZID TO PREVENT TB IN PEOPLE WITH HIV: BRIEF-TB/A5279 

Susan Swindells, Ritesh Ramchandani, Amita Gupta, Constance A. Benson, Jorge T. Leon-Cruz, Ayotunde Omoz-Oarhe, Marc Antoine Jean Juste, Javier R. Lama, Javier A. Valencia, Sharlaa Badal-Faesen, Laura E. Moran, Courtney V. Fletcher, Eric Nuermberger, Richard E. Chaisson (presenter)

*****

Monday March 5 2018, 1:30pm (in Themed Discussion TD-02, Room 304-306, “Clinical Pharmacology of HIV-TB coinfection”)

Abstract 455: EFAVIRENZ PHARMACOKINETICS IN HIV/TB COINFECTED PERSONS RECEIVING RIFAPENTINE

Anthony Podany, Erin Sizemore, Michael Chen, Neil A. Martinson, Rodney Dawson, Sharlaa Badal-Faesen, Sachiko Miyahara, Ekaterina Kurbatova, William C. Whitworth, Richard E. Chaisson, Susan E. Dorman, Payam Nahid, Kelly Dooley, Susan Swindells, for the AIDS Clinical Trials Group & Tuberculosis Trials Consortium A5349 / Study 31 Team

*****

Wednesday March 7 2018, 11:30am (in the Oral Abstract session O-12, Ballroom C “Critical Issues in women’s health and early treatment of pediatric HIV infection”)

Abstract 141: VAGINAL CONTRACEPTIVE HORMONE EXPOSURE PROFOUNDLY ALTERED BY EFV- AND ATV/R-BASED ART

Kimberly K. Scarsi, Yoninah S. Cramer, David Gingrich, Susan L. Rosenkranz, Francesca Aweeka, Robert Coombs, Carmen D. Zorrilla, Kristine Coughlin, Laura E. Moran, Baiba Berzins, Catherine Godfrey, Susan E. Cohn, for the AIDS Clinical Trials Group A5316 Study Team

*****

Poster Presentations:

Monday March 5 2018, 2:30-4pm (Poster P-F1 ANTIRETROVIRAL, ANTITUBERCULAR, AND ANTIMALARIAL PHARMACOKINETICS Poster Hall D)

Abstract 455: EFAVIRENZ PHARMACOKINETICS IN HIV/TB COINFECTED PERSONS RECEIVING RIFAPENTINE

Anthony Podany, Erin Sizemore, Michael Chen, Neil A. Martinson, Rodney Dawson, Sharlaa Badal-Faesen, Sachiko Miyahara, Ekaterina Kurbatova, William C. Whitworth, Richard E. Chaisson, Susan E. Dorman, Payam Nahid, Kelly Dooley, Susan Swindells, for the AIDS Clinical Trials Group & Tuberculosis Trials Consortium A5349 / Study 31 Team

*****

Tuesday March 6 2019, 2:30-4pm: (Poster P-F3 ANTIRETROVIRAL PHARMACOKINETICS, PHARMACOGENETICS, AND DRUG INTERACTIONS, Poster Hall D)

Abstract 466:  CYP2B6 VARIANTS ALTER ETONOGESTREL PHARMACOKINETICS WHEN COMBINED WITH EFAVIRENZ

Megan Neary, Catherine Chappell, Kimberly K. Scarsi, Shadia Nakalema, Joshua Matovu, Sharon L. Achilles, Beatrice A. Chen, Marco Siccardi, Andrew Owen, Mohammed Lamorde

See you there!


 

1 comment

Leave a comment

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

This site uses Akismet to reduce spam. Learn how your comment data is processed.